Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.00
Ask: 3.30
Change: 0.15 (5.00%)
Spread: 0.30 (10.00%)
Open: 3.10
High: 3.30
Low: 3.10
Prev. Close: 3.00
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM IN BRIEF: Quindell And ValiRx Placings; Noricum Gold Positive Results

Fri, 15th Nov 2013 07:53

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Friday:
----------
Quindell Portfolio Raises GBP200M Through Share Placing
----------
Bglobal Enters Agreement With Future Energy Solutions For Nutech Training
----------
Northbridge Industrial Services Acquires Assets of Oilfield Material Management For USD3M
----------
Armadale Capital To Buy Rest Of Netcom Global; Deal Gives It 80% Interest In Mpokoto Gold Project
----------
London Capital Finance Director Steps Down; Appoints Interim Finance Chief While It Looks For Successor
----------
Physiomics FY Turnover Up 77% To GBP240,000 Vs GBP135,306; Operating Loss Of GBP548,342 Vs GBP577,922; FY Net Loss Of GBP500,571 Vs GBP539,577; Signed A SEDA Structured Equity Deal, Won A Feasibility Grant
----------
Parkmead Group FY Pretax Loss GBP5.3M Vs GBP4.9M; Revenue Up 38% To GBP4.1 Million; FY Total Assets GBP53.4M Vs GBP22.9M; In Advanced Talks With Debt Lenders
----------
Noricum Gold: Results Continue To Reinforce High Grade Nature Of Rotguloden Project ; Visible Gold Intersected In Drill Hole C9; Drilling On-Going Underground; Looks Forward To Further Positives In Near Future
----------
GW Phamaceuticals Orphan Drug Designation Granted For Epidiolex In Dravet Syndrome By FDA
----------
Touchstone Gold Q3 Net Loss USD499,350 Vs USD2.3M; 9-Mo Net Loss USD16.9M Vs USD7.7M
----------
ValiRx To Raises GBP1M Through Share Placing
----------
Doriemus Reorganises Board, Don Strang New Chairman
----------
Frontier IP Makes New Spin-Out Company With Plymouth University; Receives 21% Stake In New Spin-Out Company PulsiV Solar
----------
Matchtech Chairman: Q1 Trading In Line With Board Expectations; Demand For Contract Recruitment Continues To Grow; Seeing First Signs Of Permanent Candidate Confidence Returning; Q1 Net Fee Income Of GBP11.1M, Up 13%; Looks Forward With Confidence To The Year Ahead
----------
Pantheon Resources FY Loss GBP700,095 Vs GBP703,602
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
26 Jul 2016 09:43

ValiRx Issues Shares To Bracknor For Loan Note Conversion (ALLISS)

Read more
14 Jul 2016 08:50

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

Read more
7 Jul 2016 07:50

ValiRx Sells TRAC Technology To Germany's Sovicell For EUR800,000

Read more
13 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.